Stoneridge Diversifies Holdings
Stoneridge Expands Diversification, Acquiring Stakes in Five Key Public Companies
Key Points
Beyond Stoneridge's new ADP stake, several other institutional investors increased their ADP positions in prior quarters (Zullo Investment Group at 1,885 shares, SBI Securities at 1,895, Nordwand Advisors at 3,205, Cary Street Partners Investment Advisory at 2,784, and Guardian Partners at 5,127), underscoring broad institutional demand for Automatic Data Processing with about 80.03% of shares held by institutions and hedge funds.
A.O. Smith: Stoneridge bought 9,510 shares in the second quarter (~$572,000), highlighting a diversification move into industrials alongside a stock with a market cap around $8.46 billion, a price-earnings ratio near 17.28, a PEG of 1.39, a beta around 1.17, and about 76.1% of shares held by institutional investors.
W.R. Berkley: Stoneridge acquired 12,324 WRB shares (~$894,000), with WRB showing roughly 68.82% institutional ownership, and trading activity including an opening around $70.54 amid a $26.19 billion market cap and a P/E of about 14.49 with a PEG near 3.22.
Solventum: Stoneridge established a new position of 8,065 shares (~$689,000) in Solventum, while other funds like United Services Automobile Association, Woodline Partners, Intech Investment Management, First Trust Advisors, and Marshall Wace also increased or initiated stakes, and analysts from BTIG, Mizuho, Wedbush, Wall Street Zen, and BMO issued coverage or target changes.
Regeneron Pharmaceuticals: Stoneridge bought 861 REGN shares (~$657,000); REGN sits with about 83.31% institutional ownership, and other institutions such as Bridgewater Advisors, USA Financial Formulas, BIP Wealth, Compound Global Advisors, and Summit Global Investments added new stakes, while analysts issued varied notes (Benchmark upgraded to Buy with a target around $185; JPMorgan and BMO adjusted targets downward or upward; Sanford C. Bernstein upgraded to Hold).
Stoneridge Investment Partners LLC went on a buying spree in the second quarter, snapping up new stakes in at least five public companies across a range of industries. The firm deployed capital in Automatic Data Processing, A. O. Smith, W.R. Berkley, Solventum, and Regeneron Pharmaceuticals, with individual positions ranging from roughly $572,000 to nearly $894,000, according to Watchlist News.
The moves signal a clear diversification push. Rather than concentrating in one sector, Stoneridge spread its bets across financial services, industrials, insurance, biopharma, and specialty chemicals. The fund also added positions in Broadridge Financial Solutions ($910,000), Realty Income ($673,000), and American Tower ($1.01 million) during the same period.
ADP and Berkley Draw the Largest Institutional Interest
Stoneridge picked up 2,213 shares of Automatic Data Processing for roughly $590,000, according to Watchlist News. ADP is one of the most institutionally owned stocks in its class — about 80.03% of shares are held by institutions and hedge funds. Stoneridge was far from alone. Zullo Investment Group, SBI Securities, Nordwand Advisors, Cary Street Partners, and Guardian Partners all increased their ADP positions in recent quarters.
On the insurance side, Stoneridge bought 12,324 shares of W.R. Berkley for about $894,000 — its largest new position in the quarter. WRB trades with a market cap near $26.19 billion and a price-to-earnings ratio of about 14.49. Institutional investors own roughly 68.82% of the company's shares. The stock opened around $70.54, giving Stoneridge a sizable entry into the property and casualty insurance space.
A. O. Smith Buy Marks a Bet on Industrials
Stoneridge added 9,510 shares of A. O. Smith for about $572,000, making it one of the fund's more volume-heavy purchases, per Watchlist News. AOS carries a market cap near $8.46 billion. Its price-to-earnings ratio sits around 17.28, with a PEG ratio of 1.39 — a sign that growth is priced in but not wildly so. The stock has a beta of about 1.17, meaning it moves slightly more than the broader market.
Institutional investors hold about 76.1% of AOS shares. The purchase fits a broader pattern of funds adding exposure to industrial names. A. O. Smith makes water heaters and water treatment products — steady, durable-demand businesses that appeal to long-term holders looking for reliable earnings.
Solventum and Regeneron Round Out the Biopharma Exposure
Stoneridge established a new 8,065-share position in Solventum worth about $689,000, according to Watchlist News. Solventum, a 3M spinoff focused on healthcare solutions, drew attention from several other funds too. United Services Automobile Association, Woodline Partners, Intech Investment Management, First Trust Advisors, and Marshall Wace all increased or started stakes. Analysts from BTIG, Mizuho, Wedbush, and BMO issued fresh coverage or adjusted price targets during the period.
In biopharma, Stoneridge bought 861 shares of Regeneron Pharmaceuticals for roughly $657,000. REGN has one of the highest institutional ownership rates in the group — about 83.31% of shares are held by institutions. Other new buyers included Bridgewater Advisors, USA Financial Formulas, BIP Wealth, Compound Global Advisors, and Summit Global Investments. Analyst opinion was mixed: Benchmark upgraded REGN to Buy with a target near $185, while JPMorgan and BMO adjusted their targets, and Sanford C. Bernstein moved to a Hold rating.
A Strategy Built on Spreading Risk Across Sectors
Taken together, Stoneridge's second-quarter moves paint a clear picture. The fund is not chasing one big theme. It is building small-to-mid-sized positions — none above $1.01 million — across real estate, industrials, insurance, payroll services, and pharma. That kind of spread limits damage if any single sector stumbles.
The activity also fits a broader Wall Street trend. Institutional investors poured into diversified, large-cap names during the quarter. High institutional ownership across all five of Stoneridge's new picks — ranging from about 68% for WRB to over 83% for REGN — suggests these are consensus-quality names. Stoneridge appears to be aligning with, not betting against, the institutional herd.
Sentiment
Mostly PositivePublishers
17
Articles
4
Reach
21
